Drugmakers would have until 2032 to cut ties with WuXi AppTec and other Chinese life sciences companies, according to an ...

Bernie Sanders (I-VT) and Jeff Merkley (D-OR) accused a new US Chamber of Commerce coalition of attempting to “stymie the ...

Bluebird bio’s stock $BLUE jumped over 20% on Thursday following its first-quarter earnings release and the announcement of ...

Several secretive and well-funded biotechs are sharing the first glimpses of data from a new suite of gene editing tools that ...

Maze Therapeutics has found a new buyer for its Pompe disease candidate, five months after scrutiny from the Federal Trade ...

Law­mak­ers in the House En­er­gy and Com­merce Com­mit­tee crit­i­cized the man­age­ment of the na­tion­al stock­pile in a ...

Gink­go Bioworks is look­ing to cut ex­pens­es and per­son­nel in an ef­fort to re­turn to prof­itabil­i­ty and break even by ...

Macro­Gen­ics re­port­ed on Thurs­day af­ter­noon that three pa­tients died in a mid-stage tri­al of its an­ti­body-drug ...

Verona Pharma has secured up to $650 million to aid the potential launch of its COPD candidate ensifentrine. Under new ...

Lykos Ther­a­peu­tics is on a jour­ney to get the first MD­MA-as­sist­ed PTSD ther­a­py ap­proved by the FDA, and the biotech ...

As the head of the trade group BIO and a parent to children with a rare disease, John Crowley is personally and ...

Rapt Therapeutics said it will close and unblind two mid-stage trials in atopic dermatitis and asthma after they were put on ...